このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Student Precarity and Psychiatry (PEPSY)

2026年6月11日 更新者:Assistance Publique - Hôpitaux de Paris

Impact of Precarity on the Emergence of Psychiatric Disorders and the Use of Care Among Students

Since the COVID-19 pandemic, mental health disorders have increased significantly, particularly among young people. In France, the proportion of young people aged 18 to 25 suffering from depression almost doubled between 2017 and 2021. This phenomenon particularly affects students, who are already identified as being at greater risk of mental health disorders than the general population. Medical students seem to be particularly vulnerable: in 2021, a national study showed very high rates of depression and suicidal thoughts in this population. The main factor associated with depression was the feeling of financial hardship.

Students often face multiple forms of insecurity. Financially, they have limited resources and struggle to cover their basic needs such as housing, food and healthcare. Socially, many experience significant isolation, particularly when they are away from their families or under pressure from their studies. All of this has a significant impact on their mental health. Unfortunately, many students do not seek help due to lack of time, resources, or awareness of support services. The 2021 study showed that only one-third of medical students suffering from depression received appropriate treatment.

The aim of our study is to assess the impact of precariousness on the onset of psychiatric disorders and on the use or non-use of healthcare services.

Our study will involve nearly 45,000 students from PSL and UPC universities. It is based on a longitudinal cohort (via questionnaires) over three years. The aim is to identify precisely the different aspects of student precariousness (housing, transport, isolation, economic difficulties, etc.) and their link with psychological distress. The study will measure the extent of the phenomenon and identify modifiable factors that could be targeted by preventive measures. The results will enable us to better target preventive measures and propose concrete solutions to improve students' well-being and promote their success.

調査の概要

状態

まだ募集していません

条件

介入・治療

詳細な説明

The COVID-19 pandemic has led to an increase in depression, particularly among young people. The French health barometer, conducted every 4-5 years by Santé Publique France (SPF), found that the prevalence of major depressive episodes (MDE) among 18-25 year olds doubled (from 11.7% to 20.8%) between 2017 and 2021. There has also been an increase in suicidal thoughts and suicide attempts. Among students, data from the 2016 Student Life Observatory (OVE) found a higher prevalence of CDE and suicidal thoughts among students than in the general population of the same age. Among the factors associated with the risk of EDC, experiencing significant financial difficulties was the main one[4]. Among medical students, a national study conducted in 2021 found that the prevalence of depression and suicidal thoughts was much higher than in the general population of the same age. Financial difficulties were also the main factor associated with the risk of depression. Indeed, students are a population that is particularly vulnerable to precariousness due to several factors. Economically, they often have limited incomes, depending on parental support, insufficient grants or precarious jobs. This exposes them to difficulties in meeting their basic needs such as housing, food and healthcare. Socially, isolation can exacerbate their situation, especially when they are far from their family network or under pressure from their studies. In addition, high academic demands, combined with unstable living conditions, impact their mental health and can contribute to the development of psychiatric disorders, which often go untreated due to a lack of affordable and accessible resources. International students are even more vulnerable due to language and administrative barriers and limited access to local support services. This multidimensional precariousness highlights the need for comprehensive support for this population, even though students are unlikely to seek professional help. In the 2021 survey, only 32% of medical students suffering from depression received adequate care. If we want to improve the health of medical students, we must not only treat disorders, but also prevent them from occurring by helping students strive for a state of well-being. In terms of prevention, the Haute Autorité de Santé (HAS) distinguishes between three levels: primary prevention, which acts upstream of the disease (on risk factors); secondary prevention, which acts at an early stage of its development (screening); and tertiary prevention, which acts on complications and the risk of recurrence.

The objectives of the study are to identify and quantify the modifiable predictive and moderating factors explaining students' psychological distress that could give rise to (primary) prevention actions by studying the various components of precariousness (housing, transport, study conditions, social isolation, grants, etc.). It also aims to study the impact of the various components of precariousness on the use and non-use of healthcare (screening and treatment, secondary and tertiary prevention).

The data will be entered directly by participants on the SKEZIA platform (https://skezi.eu/) (a solution developed by SKEZI) co-founded by AP-HP and Paris-Cité University, and will be hosted on HDS-approved servers.

Main objective:

The objective is to explore the impact of precariousness on the risk of characterised depressive episodes and the use of healthcare among PSL students (17,000 students) and UPC health faculty students (28,000 students).

Primary outcome measure:

The study will assess the 12-month prevalence of:

  • characterised depressive episodes (using the Composite International Diagnostic Interview Short-Form (CIDI-SF)) and suicidal ideation in the same way as SPF and OVE;
  • use of healthcare services, which will be measured in a similar way to the OVE survey and the medical student survey.

Precariousness will be assessed by the question: 'Would you say that you are currently experiencing financial difficulties?'

Secondary objectives and evaluation criteria:

The secondary objectives are to :

  • evaluate the prevalence of :
  • anxiety, which will be assessed using the GAD7;
  • eating disorders, which will be assessed using the SCOFF;
  • alcohol addiction, which will be assessed using the AUDIT, and cannabis addiction, which will be assessed using the CAST;
  • burnout, using the student version, which will be assessed using the MBI-SS for pre-clinical or healthcare students and the MBI-HSS for externs and residents,
  • dropout, which will be assessed by a single question as in the CNA-CORE survey,
  • insomnia, which will be measured by the Insomnia Severity Index (ISI),
  • loneliness, which will be assessed using the UCLA 3 items,
  • harassment,
  • discriminatory treatment,
  • and quality of life (WHOQOL);
  • identify and quantify modifiable predictive and moderating factors explaining students' psychological distress that could lead to (primary) prevention measures = by studying the various components of precariousness (housing, transport, study conditions, social isolation, grants, etc.),
  • study the impact of the various components of precariousness on the use and non-use of healthcare (screening and treatment, secondary and tertiary prevention). This will be assessed using questions on the renunciation of healthcare and its causes.

研究の種類

観察的

入学 (推定)

45000

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

サンプリング方法

非確率サンプル

調査対象母集団

All students enrolled at Paris Sciences et Lettres University or the Faculty of Health Sciences at Paris Cité University.

説明

Inclusion Criteria:

  • Student enrolled at Paris Sciences et Lettres University (PSL, 17,000 students) or the Faculty of Health Sciences at Paris Cité University (UPC, 28,000 students),
  • Aged 18 or over,
  • Fluent in French,
  • Affiliated to a health insurance.

Exclusion Criteria:

  • Applicants under the age of 18,
  • Not enrolled at PSL universities or the UPCS Faculty of Health,
  • Insufficient level of French.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
介入・治療
Health students
All students enrolled at the Faculty of Health Sciences of Paris Cité University
アンケート
Non-health students
All students enrolled at Paris Sciences and Letters University
アンケート

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Composite International Diagnostic Interview Short-Form (CIDI-SF)
時間枠:Day 0
12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)
Day 0
Composite International Diagnostic Interview Short-Form (CIDI-SF)
時間枠:12 months
12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)
12 months
Use of care
時間枠:Day 0
Use of care service of care professional
Day 0
Use of care
時間枠:12 months
Use of care service of care professional
12 months
Precarity
時間枠:Day 0
Question "Would you say that you are currently experiencing financial difficulties?"
Day 0
Precarity
時間枠:12 months
Question "Would you say that you are currently experiencing financial difficulties?"
12 months

二次結果の測定

結果測定
メジャーの説明
時間枠
GAD7
時間枠:Day 0
Prevalence of anxiety
Day 0
GAD7
時間枠:12 months
Prevalence of anxiety
12 months
GAD7
時間枠:24 months
Prevalence of anxiety
24 months
SCOFF
時間枠:Day 0
Prevalence of Eating disorders
Day 0
SCOFF
時間枠:12 months
Prevalence of Eating disorders
12 months
SCOFF
時間枠:24 months
Prevalence of Eating disorders
24 months
AUDIT
時間枠:Day 0
Prevalence of Alcohol addiction
Day 0
AUDIT
時間枠:12 months
Prevalence of Alcohol addiction
12 months
AUDIT
時間枠:24 months
Prevalence of Alcohol addiction
24 months
CAST
時間枠:Day 0
Prevalence of cannabis addiction
Day 0
CAST
時間枠:12 months
Prevalence of cannabis addiction
12 months
CAST
時間枠:24 months
Prevalence of cannabis addiction
24 months
MBI-SS or MBI-HSS
時間枠:Day 0
Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents
Day 0
MBI-SS or MBI-HSS
時間枠:12 months
Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents Time Frame: D0
12 months
MBI-SS or MBI-HSS
時間枠:24 months
Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents Time Frame: D0
24 months
A single question as in the CNA-CORE survey
時間枠:Day 0
Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey
Day 0
A single question as in the CNA-CORE survey
時間枠:12 months
Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey
12 months
A single question as in the CNA-CORE survey
時間枠:24 months
Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey
24 months
Insomnia Severity Index (ISI)
時間枠:Day 0
Prevalence of Insomnia
Day 0
Insomnia Severity Index (ISI)
時間枠:12 months
Prevalence of Insomnia
12 months
Insomnia Severity Index (ISI)
時間枠:24 months
Prevalence of Insomnia
24 months
UCLA 3 items
時間枠:Day 0
Prevalence of Loneliness
Day 0
UCLA 3 items
時間枠:12 months
Prevalence of Loneliness
12 months
UCLA 3 items
時間枠:24 months
Prevalence of Loneliness
24 months
Questions about harrassment
時間枠:Day 0
Harrassment
Day 0
Questions about harrassment
時間枠:12 months
Harrassment
12 months
Questions about harrassment
時間枠:24 months
Harrassment
24 months
Questions about discriminatory treatment
時間枠:Day 0
Discriminatory treatment
Day 0
Questions about discriminatory treatment
時間枠:12 months
Discriminatory treatment
12 months
Questions about discriminatory treatment
時間枠:24 months
Discriminatory treatment
24 months
WHOQOL
時間枠:Day 0
Quality of life
Day 0
WHOQOL
時間枠:12 months
Quality of life
12 months
WHOQOL
時間枠:24 months
Quality of life
24 months
Components of precariousness
時間枠:Day 0
Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).
Day 0
Components of precariousness
時間枠:12 months
Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).
12 months
Questions on the renunciation of healthcare and its causes.
時間枠:12 months
Impact of the various components of precariousness on the use and non-use of healthcare will be assessed using questions on the renunciation of healthcare and its causes.
12 months
Components of precariousness
時間枠:24 months
Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).
24 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

協力者

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月1日

一次修了 (推定)

2028年9月1日

研究の完了 (推定)

2028年11月1日

試験登録日

最初に提出

2026年3月4日

QC基準を満たした最初の提出物

2026年5月26日

最初の投稿 (実際)

2026年6月1日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月15日

QC基準を満たした最後の更新が送信されました

2026年6月11日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • APHP251300
  • N°IDRCB : 2025-A01968-41 (その他の識別子:France : Ministry of Health)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。